We are delighted top announce the launch of our first newsletter. This is a chance to provide GPs and other healthcare professionals with an update on changes in urology, share our thoughts and tips for the management of urological disorders in primary care, and also provide an overview on the services we offer patients.

After a sabbatical from private practice we are delighted that Andrew Doble has rejoined the practice. Andrew is a recognised leader in the field of prostate cancer and protatitis, and has a wealth of experience in the field of urology. He has further interests in minimally invasive treatments such as cryotherapy for kidney cancer. Andrew has recently been elected to the renal cancer Clinical Studies Group at the NCRI and is also a committee member of the British Prostate Group (BPG). He has been a consultant at Addenbrooke's Hospital since 1993. To read more about him, please click here

Christof is a Consultant Urologist based at Addenbrooke's Hospital, Cambridge and at Hinchingbrooke Hospital, Huntingdon. He also leads the collaboration with primary care on shared Urology care. Click here to read more.

He is experienced in the management of general urological problems and specialises in the diagnosis and treatment of benign and malignant prostatic disease using imaging and technology-based approaches, including Holmium Laser prostatectomy and Brachytherapy.

His publications relate to the management of benign and malignant prostatic disease and the assessment of new technologies.

He is actively involved in training urology registrars on rotation in the East of England and mentoring surgeons learning Holmium Laser prostatectomy. He is faculty member on both national Laser courses at Guy's Hospital and Addenbrooke's Hospital. Christof advises on the development of brachytherapy for prostate cancer on an international level.

Cambridge Urology Partnership are delighted to launch their new website. The site has been under development for a number of months, and aims to provide patients and other medical practitioners with information about us and our services. We have also included details of many urological conditions on the site, together with information leaflets. Where patients or relatives seek further information, we have provided links to other resources.

Through the site GPs can also sign up for our twice yearly Urology Newsletter (link to newsletter sign-up), which will provide updates which are occurring in urology and in the services offered to our patients by Cambridge Urology Partnership. We are always happy to receive feedback on the site from patients or other medical professionals.

With the installation of a new CT scanner at The Spire Cambridge Lea Hospital, patients with suspected kidney stone now get rapid and state of the art investigation. Where possible, we will arrange for you to have your CT scan on the same day as your appointment, so that you can leave the clinic knowing if you have a kidney stone, and if so where it is and how it will be treated. Two of the Cambridge Urology Partnership urologists, Nimish Shah and Oliver Wiseman, are recognised specialists in the management and diagnosis of kidney stones.

Prostate Cancer gene 3 (PCA3) is a new gene-based test carried out on a urine sample. PCA3 is highly specific to prostate cancer and this gene is overexpressed in over 95% of prostate cancer cases. This is in contrast to PSA (prostate specific antigen, the blood test that is most commonly used to look for evidence of prostate cancer) which may be increased by conditions such as benign enlargement of the prostate (BPH or BPE) or inflammation of the prostate (prostatitis). The PCA3 test result is not affected by these conditions. To read more about PCA3, please click here.